Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

22 August 2025 : Review article  

A Review of Modulation of Gut Microbiota to Mitigate Gestational Diabetes: Implications for Maternal and Child Health

Olimpia Mora-Janiszewska ORCID logo ABCDEF 1, Kinga Bialic ORCID logo ABCDEF 1*, Anna Faryniak BF 1, Dorota Darmochwał-Kolarz ORCID logo BF 1

DOI: 10.12659/MSM.948897

Med Sci Monit 2025; 31:e948897

Figure 1 Key points discussed in the article, highlighting the main mechanisms and potential strategies for gut microbiota modulation in the prevention of GDM metabolic complications. The gut microbiota plays a fundamental role in metabolic regulation and may influence both the development of gestational diabetes mellitus (GDM) and the long-term health of offspring. 1. Appropriate nutritional and probiotic interventions may help prevent the metabolic consequences of GDM in future generations by influencing epigenetic mechanisms of inheritance. 2, 3. Alterations in the composition of the intestinal microbiota can modulate epigenetic mechanisms that regulate insulin resistance, for example, by affecting DNA methylation of genes involved in glucose and lipid metabolism. Intestinal dysbiosis leads to an increased production of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), which exacerbate insulin resistance. Short-chain fatty acids (SCFAs), produced through the microbial fermentation of dietary fiber, can influence gene expression by modulating histone modifications and microRNA (miRNA) regulation. These changes may improve insulin signalling and reduce inflammation. Additionally, microbial metabolites can regulate hormone levels such as leptin and ghrelin, which are involved in appetite and energy homeostasis. 4, 5. Gut microbiota may also impact the development of gestational diabetes mellitus and metabolic programming of offspring via epigenetic gene regulation. Modulation of microbiota through dietary strategies, including probiotics and prebiotics, offers a promising approach to reducing the risk of metabolic complications associated with GDM. Figure created using Canva (version current as of 2025; Canva Pty Ltd, Australia).

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750